A new UB study conducted at John R. Oishei Children’s Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in children (MIS-C) during the omicron ...
The idea that the omicron subvariant of COVID-19 causes mild infection depends on just what it’s being compared to, experts say. It is less lethal than the delta variant, but—for the unvaccinated—it’s ...
In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 ...
BUFFALO, N.Y. – A new University at Buffalo study conducted at John R. Oishei Children’s Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in ...
Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The Uplift," ...
Patients hospitalized with the omicron or delta variants of COVID-19 required similar levels of respiratory support and intensive care, according to a new Johns Hopkins study, indicating that omicron ...
The omicron variant of the coronavirus is substantially less likely than the earlier delta variant to cause symptoms of long COVID-19, according to a new study. The study from researchers in the ...
In a recent study published in Nature Medicine, researchers compared coronavirus disease 2019 (COVID-19) severity outcomes among individuals infected with the severe acute respiratory syndrome ...
A backdated study from JAMA Pediatrics revealed that hospital admission rates were significantly higher for respiratory syncytial virus (RSV) compared with the omicron strain of COVID or the flu. The ...
April 1 (UPI) --During the surge in cases fueled by the Omicron variant, children age 5 years and younger caught COVID-19 at rates six- to eight-fold higher than those seen with the Delta strain, a ...
A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 Omicron variant, according to a new study. A recent Pfizer or Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results